Leerink Partners Maintains Outperform on AdaptHealth, Lowers Price Target to $12
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $13 to $12.
Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $13 to $12.